» Articles » PMID: 35355895

Quality of Conduct and Reporting of Propensity Score Methods in Studies Investigating the Effectiveness of Antimicrobial Therapy

Overview
Date 2022 Mar 31
PMID 35355895
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Propensity score methods are becoming increasingly popular in infectious disease medicine to correct for confounding in observational studies. However, applying and reporting propensity score techniques correctly requires substantial knowledge of these methods. The quality of conduct and reporting of propensity score methods in studies investigating the effectiveness of antimicrobial therapy is yet undetermined.

Methods: A systematic review was performed to provide an overview of studies (2005-2020) on the effectiveness of antimicrobial therapy that used propensity score methods. A quality assessment tool and a standardized quality score were developed to evaluate a subset of studies in which antibacterial therapy was investigated in detail. The scale of this standardized score ranges between 0 (lowest quality) and 100 (excellent).

Results: A total of 437 studies were included. The absolute number of studies that investigated the effectiveness of antimicrobial therapy and that used propensity score methods increased 15-fold between the periods 2005-2009 and 2015-2019. Propensity score matching was the most frequently applied technique (65%), followed by propensity score-adjusted multivariable regression (25%). A subset of 108 studies was evaluated in detail. The median standardized quality score per year ranged between 53 and 61 (overall range: 33-88) and remained constant over the years.

Conclusions: The quality of conduct and reporting of propensity score methods in research on the effectiveness of antimicrobial therapy needs substantial improvement. The quality assessment instrument that was developed in this study may serve to help investigators improve the conduct and reporting of propensity score methods.

Citing Articles

Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).

Gentile I, Giaccone A, Scirocco M, Di Brizzi F, Cuccurullo F, Silvitelli M BMC Infect Dis. 2024; 24(1):1434.

PMID: 39696011 PMC: 11653931. DOI: 10.1186/s12879-024-10303-5.


Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.

Matsushita K, Delmas C, Marchandot B, Roubille F, Lamblin N, Leurent G J Am Heart Assoc. 2024; 13(5):e030975.

PMID: 38390813 PMC: 10944045. DOI: 10.1161/JAHA.123.030975.


Association of SGLT-2 Inhibitors With Treatment Satisfaction and Diabetes-Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 Diabetes.

Ding Q, Spatz E, Bena J, Morrison S, Levay M, Lin H J Am Heart Assoc. 2023; 12(17):e029058.

PMID: 37655510 PMC: 10547320. DOI: 10.1161/JAHA.122.029058.


Transcatheter Ductal Stents Versus Surgical Systemic-Pulmonary Artery Shunts in Neonates With Congenital Heart Disease With Ductal-Dependent Pulmonary Blood Flow: Trends and Associated Outcomes From the Pediatric Health Information System Database.

Valencia E, Staffa S, Kuntz M, Zaleski K, Kaza A, Maschietto N J Am Heart Assoc. 2023; 12(17):e030528.

PMID: 37589149 PMC: 10547312. DOI: 10.1161/JAHA.123.030528.


Confounding adjustment in observational studies on cardiothoracic interventions: a systematic review of methodological practice.

Velders B, Taco Boltje J, Vriesendorp M, Klautz R, le Cessie S, Groenwold R Eur J Cardiothorac Surg. 2023; 64(4).

PMID: 37505476 PMC: 10597584. DOI: 10.1093/ejcts/ezad271.


References
1.
Penning de Vries B, van Smeden M, Rosendaal F, Groenwold R . Title, abstract, and keyword searching resulted in poor recovery of articles in systematic reviews of epidemiologic practice. J Clin Epidemiol. 2020; 121:55-61. DOI: 10.1016/j.jclinepi.2020.01.009. View

2.
Austin P . Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009; 28(25):3083-107. PMC: 3472075. DOI: 10.1002/sim.3697. View

3.
Goetghebeur E, le Cessie S, De Stavola B, Moodie E, Waernbaum I . Formulating causal questions and principled statistical answers. Stat Med. 2020; 39(30):4922-4948. PMC: 7756489. DOI: 10.1002/sim.8741. View

4.
Austin P, Grootendorst P, Anderson G . A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2006; 26(4):734-53. DOI: 10.1002/sim.2580. View

5.
Austin P . Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007; 134(5):1128-35. DOI: 10.1016/j.jtcvs.2007.07.021. View